Orthofix Medical Inc. (NASDAQ:OFIX - Get Free Report) insider Jorge Andres Cedron sold 3,816 shares of the company's stock in a transaction that occurred on Wednesday, April 16th. The shares were sold at an average price of $13.31, for a total value of $50,790.96. Following the completion of the transaction, the insider now owns 42,500 shares in the company, valued at $565,675. This represents a 8.24 % decrease in their ownership of the stock. The transaction was disclosed in a legal filing with the SEC, which can be accessed through this link.
Orthofix Medical Stock Up 0.5 %
Shares of OFIX opened at $13.03 on Friday. The company has a debt-to-equity ratio of 0.25, a quick ratio of 1.11 and a current ratio of 2.39. The stock has a market capitalization of $508.46 million, a PE ratio of -4.16 and a beta of 0.99. The company's 50-day simple moving average is $16.25 and its 200-day simple moving average is $17.15. Orthofix Medical Inc. has a 1 year low of $12.08 and a 1 year high of $20.73.
Analysts Set New Price Targets
Several equities analysts have recently commented on OFIX shares. StockNews.com raised Orthofix Medical from a "hold" rating to a "buy" rating in a research note on Tuesday, February 25th. Roth Mkm reaffirmed a "buy" rating and set a $22.00 target price on shares of Orthofix Medical in a research note on Wednesday, February 26th. Finally, Canaccord Genuity Group reissued a "buy" rating and issued a $24.00 price target on shares of Orthofix Medical in a research note on Wednesday, February 26th. One analyst has rated the stock with a hold rating and five have assigned a buy rating to the company. According to MarketBeat.com, the stock currently has an average rating of "Moderate Buy" and an average price target of $23.33.
Read Our Latest Stock Analysis on OFIX
Hedge Funds Weigh In On Orthofix Medical
Hedge funds and other institutional investors have recently added to or reduced their stakes in the business. Assenagon Asset Management S.A. increased its position in shares of Orthofix Medical by 421.1% during the first quarter. Assenagon Asset Management S.A. now owns 72,226 shares of the medical device company's stock worth $1,178,000 after acquiring an additional 58,366 shares during the period. GAMMA Investing LLC raised its position in Orthofix Medical by 1,585.1% in the 1st quarter. GAMMA Investing LLC now owns 22,867 shares of the medical device company's stock valued at $373,000 after purchasing an additional 21,510 shares in the last quarter. UBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC boosted its stake in shares of Orthofix Medical by 14.0% in the 4th quarter. UBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC now owns 71,371 shares of the medical device company's stock valued at $1,246,000 after buying an additional 8,772 shares during the period. Soleus Capital Management L.P. grew its position in shares of Orthofix Medical by 13.1% during the fourth quarter. Soleus Capital Management L.P. now owns 686,374 shares of the medical device company's stock worth $11,984,000 after buying an additional 79,441 shares in the last quarter. Finally, State of Wyoming increased its stake in shares of Orthofix Medical by 206.8% during the fourth quarter. State of Wyoming now owns 9,432 shares of the medical device company's stock worth $165,000 after buying an additional 6,358 shares during the period. Hedge funds and other institutional investors own 89.76% of the company's stock.
Orthofix Medical Company Profile
(
Get Free Report)
Orthofix Medical Inc operates as a spine and orthopedics company in the United States, Italy, Germany, the United Kingdom, France, Brazil, and internationally. It operates through two segments, Global Spine and Global Orthopedics. The Global Spine segment manufactures and distributes bone growth stimulator devices for enhance of bone fusion, including adjunctive and noninvasive treatment of cervical and lumbar spine, as well as a therapeutic treatment for non-spine; designs, develops, and markets a portfolio of motion preservation and fixation implant products, which are used in surgical procedures of the spine; and offers biological products, such as fiber-based and particulate demineralized bone matrices, cellular bone allografts, collagen ceramic matrices, and synthetic bone void fillers, and tissue forms, which allow physicians to treat various spinal and orthopedic conditions.
Featured Articles
This instant news alert was generated by narrative science technology and financial data from InsiderTrades.com in order to provide readers with the fastest and most accurate reporting. This story was reviewed by InsiderTrades.com's editorial team prior to publication. Please send any questions or comments about this story to contact@insidertrades.com.
